Altria Reports Q4/Full-Year 2025 Results with $2.2B E-Vapor Impairment; Provides 2026 Guidance
summarizeSummary
Altria reported its 2025 financial results, including a significant $2.2 billion non-cash impairment charge in its e-vapor segment and declining volumes in smokeable products, while providing modest 2026 adjusted EPS guidance.
check_boxKey Events
-
Significant E-Vapor Impairment
Altria recorded $2.2 billion in non-cash impairment charges for its e-vapor reporting unit goodwill and intangible assets in 2025, reflecting struggles in this segment.
-
Declining Core Product Volumes
Smokeable product shipment volume decreased 10.0% for the full year 2025, and oral tobacco product volume decreased 5.5%, indicating ongoing challenges in traditional segments.
-
Modest Adjusted EPS Growth & Guidance
Full-year 2025 adjusted diluted EPS grew 4.4% to $5.42, with 2026 guidance set at $5.56 to $5.72, representing 2.5% to 5.5% growth.
-
Board Appointment
Salvatore Mancuso was elected to the Board of Directors, effective January 29, 2026, ahead of his previously announced CEO appointment in May 2026.
auto_awesomeAnalysis
Altria's latest earnings report reveals a challenging landscape, primarily marked by a substantial $2.2 billion non-cash impairment charge related to its e-vapor business, signaling significant struggles in this growth area. The company also experienced continued declines in shipment volumes for its core smokeable products and oral tobacco products, with Marlboro's retail share decreasing. While Altria reported a 4.4% increase in adjusted diluted EPS for 2025 and provided 2026 guidance for modest growth (2.5% to 5.5%), these positive aspects are overshadowed by the underlying operational challenges and the large write-down. Investors should monitor the company's ability to stabilize its traditional segments and demonstrate a viable path for its smoke-free portfolio amidst regulatory and competitive pressures. The appointment of Salvatore Mancuso to the Board, ahead of his previously announced CEO role, is a routine governance update.
At the time of this filing, MO was trading at $63.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $106B. The 52-week trading range was $50.08 to $68.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.